Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis

OBJECTIVE: Breast cancer (BC) with chest wall metastasis (CWM) usually shows rich neovascularization. This trial explored the clinical effect of apatinib on human epidermal growth factor receptor 2 (HER2)-negative advanced BC involving CWM. METHODS: This trial involved four centers in China and was...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huiping, Geng, Cuizhi, Zhao, Hongmei, Jiang, Hanfang, Song, Guohong, Zhang, Jiayang, Liu, Yaxin, Gui, Xinyu, Wang, Jing, Li, Kun, Tong, Zhongsheng, Zhao, Fangyuan, Yang, Junlan, Chen, Guoliang, Liu, Qianyu, Liang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181870/
https://www.ncbi.nlm.nih.gov/pubmed/34158743
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.02.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181870/
https://www.ncbi.nlm.nih.gov/pubmed/34158743
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.02.11

Ejemplares similares